96.50NOK-2.53%Mkt Cap: 791.32M $P/E: —1d ago
Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. The company operates through three segments: Human Health Ingredients (HHI), Consumer Heal…
Indicators:|
Key Statistics
Company
Market Cap791.32M $
Enterprise Value807.58M $
Revenue (TTM)21.00M $
Gross Profit9.14M $
Net Income (TTM)-2.13M $
Revenue/Share0.2394 USD
Last Price96.50 NOK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees258
CountryNO
SectorConsumer Defensive
IndustryPackaged Foods
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)21.66
PEG—
EV/EBITDA220.39
EV/Revenue38.47
P/S37.69
P/B6.11
EPS (TTM)-0.30
EPS (Forward)4.46
52W Range
58.6064% of range118.00
52W High118.00 NOK
52W Low58.60 NOK
Profitability
Gross Margin44.84%
Oper. Margin6.63%
EBITDA Margin17.45%
Profit Margin-10.45%
ROE-15.83%
ROA-5.86%
Growth
Revenue Growth12.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF392.61K $
CapEx (TTM)850.65K $
FCF Margin13.95%
FCF Yield0.37%
Net Debt16.44M $
Net Debt/EBITDA4.49
Balance Sheet
Debt/Equity1.26
Current Ratio3.32
Quick Ratio1.20
Book Value/Sh15.79 NOK
Cash/Share0.2260 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 NOK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateSep 9, 2024
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)128.15 NOK
Upside (mean)+32.8%
Target Range128.15 NOK – 128.15 NOK
# Analysts1
Ownership
Shares Out.87.72M
Float9.05M
Insiders89.32%
Institutions5.70%
Technical
SMA 50101.86 (-5.3%)
SMA 20096.46 (+0.0%)
Beta0.30
S&P 52W Chg20.05%
Avg Vol (30d)29.47K
Avg Vol (10d)9.00K
Technical Indicators
RSI (14)38.1
MACD-1.4985
MACD Signal-1.5535
MACD Hist.+0.0550
BB Upper105.19 NOK
BB Middle98.98 NOK
BB Lower92.77 NOK
BB Width12.54%
ATR (14)3.284 NOK
Vol Ratio (20d)0.33x